An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in China.
OBJECTIVE
To investigate specific changes in metabolites and proteins of Kidney-Yin Deficiency Syndrome (KYDS) patients with diabetes mellitus (DM) in China.


METHODS
KYDS (n=29) and non-KYDS (n=23) patients with DM were recruited for this study. The KYDS was diagnosed by two senior TCM clinicians separately. The metabonomic and proteomic profiles of the patients were assessed using a metabonomic strategy based on NMR with multivariate analysis and a proteomic strategy based on MALDI-TOF-MS, respectively.


RESULTS
Eighteen upregulated peptides and thirty downregulated peptides were observed in the plasma of the KYDS patients. Comparing the proteomic profiles of the KYDS and non-KYDS groups, however, no significantly differentially expressed peptides were found. At the same time, major metabolic alterations were found to distinguish the two groups, including eight significantly changed metabolites (creatinine, citrate, TMAO, phenylalanine, tyrosine, alanine, glycine and taurine). The levels of creatinine, citrate, TMAO, phenylalanine and tyrosine were decreased, whereas the levels of alanine, glycine and taurine were increased in the KYDS patients. These biochemical changes were found to be associated with alterations in amino acid metabolism, energy metabolism and gut microflora.


CONCLUSIONS
The identification of distinct expression profiles of metabolites and signaling pathways in KYDS patients with DM suggests that there are indeed molecular signatures underlying the principles of 'Syndrome Differentiation' in traditional Chinese medicine.
Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Ning
N
Jiang
Dongzhimen Hospital of Beijing University of Chinese Medicine, Beijing 100050, China.
Hong-fang
HF
Liu
Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Si-di
SD
Li
Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Wen-xia
WX
Zhou
Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China.
Yong-xiang
YX
Zhang
National Center of Biomedical Analysis, Beijing 100850, China.
Qi
Q
Zhang
National Center of Biomedical Analysis, Beijing 100850, China.
Xian-zhong
XZ
Yan
D000368:Aged; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001798:Blood Proteins / Q000032:analysis*; D016022:Case-Control Studies; D002681:China; D003920:Diabetes Mellitus / Q000097:blood* / Q000175:diagnosis / Q000652:urine*; D005260:Female; D006801:Humans; D007668:Kidney / Q000378:metabolism*; D008297:Male; D055432:Metabolomics / Q000379:methods*; D008875:Middle Aged; D015999:Multivariate Analysis; D011237:Predictive Value of Tests; D040901:Proteomics / Q000379:methods*; D066244:Proton Magnetic Resonance Spectroscopy; D015398:Signal Transduction; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D049490:Systems Biology; D018511:Systems Integration; D016482:Urinalysis; D016710:Yin Deficiency / Q000097:blood* / Q000175:diagnosis / Q000652:urine*
D015415:Biomarkers; D001798:Blood Proteins